Peter Taylor, MD
Clinical Cardiac Electrophysiology · Orlando, FLNPI 1053373290
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $28,025 of the $39,915 with a category attached, or 70.2%. Abbott accounts for 80.3% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2019 at $16,922 and has fallen 90.6% since, to $1,599 in 2025.
Across 331 payments — averaging $120.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$32K
- Kestra Medical Technology Services, Inc.$2K
- Medtronic$816
- Boston Scientific$559
- Novartis$535
- E.r. Squibb & Sons, L.L.C.$367
- plus $3K from 27 others
Across 14 payments — averaging $1247.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$13K
- Boston Scientific$4K
What the payments were for
- Consulting fees$28,02570%
- Speaking & faculty fees$1,6504%
- Travel & lodging$1,2673%
- Food & beverage$8,81922%
- Education$1000%
- Gifts$540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 130 | $32,036 |
| Kestra Medical Technology Services, Inc. | 22 | $2,418 |
| Medtronic(2 entities) | 30 | $816 |
| Boston Scientific | 15 | $559 |
| Novartis | 16 | $535 |
| E.r. Squibb & Sons, L.L.C. | 14 | $367 |
| AstraZeneca | 10 | $316 |
| Shockwave Medical, Inc | 2 | $314 |
| Cvrx, Inc. | 5 | $234 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 19 | $231 |
| Medical Device Business Services, Inc. | 1 | $204 |
| Impulse Dynamics (USA) Inc. | 4 | $175 |
| Pfizer | 8 | $169 |
| Biotronik Inc. | 2 | $161 |
| Alnylam Pharmaceuticals Inc. | 2 | $160 |
| Bridgebio Pharma, Inc. | 3 | $160 |
| Johnson & Johnson | 3 | $154 |
| Abiomed | 2 | $151 |
| Elutia, Inc. | 23 | $141 |
| Akcea Therapeutics, Inc. | 1 | $126 |
| Philips North America LLC | 1 | $122 |
| Boehringer Ingelheim | 3 | $56 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $55 |
| Amgen | 3 | $53 |
| Bayer | 2 | $44 |
| Edwards Lifesciences | 1 | $35 |
| Atricure, Inc. | 1 | $26 |
| Lexicon Pharmaceuticals, Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Scpharmaceuticals Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Assurity Pacemaker$6,350
- Anthem CRT Pacemaker$5,800
- Accent Pacemaker$5,175
- Ensite Cardiac Mapping System$3,150
- Allure CRT Pacemaker$2,900
- ACCENT$2,588
- Assure WCD$2,024
- Fortify Assura, Ellipse ICD$1,850
- AVEIR$989
- Endurity Pacemaker$850
- GALLANT$563
- ALLURE$450
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$314
- LINQ II$276
- Carto 3$204
- Barostim Neo System$144
- BioMonitor$140
- XARELTO$133
- OPTIMIZER$131
- WAINUA$129
How this compares
$39,915 in reported general payments places this provider in the 65th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 21 | $652,025 |
| EliquisApixaban | 294 | $348,225 |
| EntrestoSacubitril/Valsartan | 78 | $102,846 |
| FarxigaDapagliflozin Propanediol | 71 | $75,483 |
| XareltoRivaroxaban | 43 | $57,077 |
| JardianceEmpagliflozin | 36 | $55,805 |
| MultaqDronedarone Hcl | 23 | $32,913 |
| Dofetilide | 44 | $5,461 |
| Flecainide Acetate | 94 | $3,837 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 61 | $2,255 |
| Metoprolol Succinate | 182 | $2,036 |
| Hydralazine Hcl | 30 | $1,222 |
| Rosuvastatin Calcium | 79 | $1,099 |
| Diltiazem Hcl | 29 | $1,085 |
| Amiodarone Hcl | 57 | $1,027 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerVyndamax, Eliquis | $169 | $1,000,250315 claims |
| NovartisEntresto | $535 | $102,84678 claims |
| AstraZenecaFarxiga | $316 | $75,48371 claims |
| Johnson & JohnsonXarelto | $154 | $57,07743 claims |
| Boehringer IngelheimJardiance | $56 | $55,80536 claims |
| Sanofi-aventis U.S. LLCMultaq | $13 | $32,91323 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Orlando
- Shravan AmbatiOrlando$161K
- George MonirOrlando$70K
- Usman SiddiquiWinter Park$1.2M
- Jose Osorio FilhoMiami$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
- Parikshit SharmaWeston$462K
- Saumil OzaJacksonville$462K
- Brian BetenskySarasota$412K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.